Literature DB >> 15477456

Optical coherence tomography findings in myopic traction maculopathy.

Giacomo Panozzo1, Andrea Mercanti.   

Abstract

OBJECTIVE: To describe the features and incidence of epiretinal traction and related retinal damage in degenerative myopia.
DESIGN: Consecutive observational case series.
METHODS: We retrospectively reviewed medical records and optical coherence tomography findings of 218 eyes with high myopia of 121 consecutive patients to detect the incidence and features of epiretinal traction-related macular damage. The degree of myopia ranged from -8 to -26 spherical equivalent (mean +/- SD, -16.93 +/- 5.74). Mean +/- SD axial length was 29.75 +/- 2.12 mm. Excluding eyes with possibly confounding features, 125 eyes were analyzed. MAIN OUTCOME MEASURE: Detection of epiretinal traction and related macular damage.
RESULTS: Epiretinal traction was found in 58 (46.4%) of 125 eyes and retinal damage, in 43 eyes (34.4%). Macular retinoschisis was the most frequent form of macular damage (25 eyes [58%]), followed by retinal thickening, lamellar hole, and shallow retinal detachment.
CONCLUSIONS: Epiretinal traction is a frequent finding in degenerative myopia and, particularly if associated with the presence of staphyloma, can generate a form of macular damage unique to eyes with high myopia. This damage can affect up to one third of these eyes and should be considered as a separate cause of visual loss easily detected by optical coherence tomography at its early stages.

Entities:  

Mesh:

Year:  2004        PMID: 15477456     DOI: 10.1001/archopht.122.10.1455

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  86 in total

1.  Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis.

Authors:  Su Jin Lim; Yoon Hyung Kwon; Soon Hyun Kim; Yong Sung You; Oh Woong Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

2.  Myopic foveoschisis: an ectatic retinopathy, not a schisis.

Authors:  M K Tsilimbaris; D G Vavvas; N E Bechrakis
Journal:  Eye (Lond)       Date:  2015-11-20       Impact factor: 3.775

3.  Vitrectomy and gas tamponade without internal limiting membrane peeling for myopic foveoschisis.

Authors:  A K H Kwok; T Y Y Lai; W W K Yip
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Assessment of OCT measurements as prognostic factors in myopic macular hole surgery without foveoschisis.

Authors:  Micol Alkabes; Leyla Padilla; Cecilia Salinas; Paolo Nucci; Lucia Vitale; Francesco Pichi; Anniken Burès-Jelstrup; Carlos Mateo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 3.117

5.  Macular cysts, holes and cavitations : 2006 Jules Gonin lecture of the Retina Research Foundation.

Authors:  A Gaudric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-30       Impact factor: 3.117

6.  Myopic traction maculopathy: study with spectral domain optical coherence tomography and review of the literature.

Authors:  V Konidaris; S Androudi; P Brazitikos
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 7.  Advances of optical coherence tomography in myopia and pathologic myopia.

Authors:  D S C Ng; C Y L Cheung; F O Luk; S Mohamed; M E Brelen; J C S Yam; C W Tsang; T Y Y Lai
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

8.  Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization.

Authors:  Noriaki Shimada; Kyoko Ohno-Matsui; Kengo Hayashi; Takeshi Yoshida; Takashi Tokoro; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2011-05-27       Impact factor: 2.447

9.  Comparison of spectral domain and swept-source optical coherence tomography in pathological myopia.

Authors:  L S Lim; G Cheung; S Y Lee
Journal:  Eye (Lond)       Date:  2014-01-17       Impact factor: 3.775

10.  Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature.

Authors:  Niranjan Kumar; Jamal Al Kandari; Khalid Al Sabti; Vivek B Wani
Journal:  J Med Case Rep       Date:  2010-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.